123 related articles for article (PubMed ID: 3051581)
1. Optimal results in cadaveric renal transplantation with low-dose cyclosporine and steroids combined with prophylactic anti-lymphocyte globulin.
Fries D; Hiesse C; Charpentier B; Cantarovich M; Lantz O; Benoit G
Transplant Proc; 1988 Oct; 20(5 Suppl 6):23-5. PubMed ID: 3051581
[No Abstract] [Full Text] [Related]
2. Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.
Griño JM; Alsina J; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andrés E; Sabater R
Transplant Proc; 1988 Oct; 20(5 Suppl 6):18-20. PubMed ID: 3051579
[No Abstract] [Full Text] [Related]
3. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
4. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
Awni WM; Heim-Duthoy K; Kasiske BL
Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
[No Abstract] [Full Text] [Related]
5. Is sequential low-dose immunotherapy the preferred treatment in cadaveric renal transplantation?
Posner MP; Mendez-Picon G; King A; Nelson KP; Spicer HG; Lee HM
Transplant Proc; 1989 Feb; 21(1 Pt 2):1594-7. PubMed ID: 2652519
[No Abstract] [Full Text] [Related]
6. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy.
Hourmant M; Buzelin F; Dubigeon P; Soulillou JP
Transplant Proc; 1987 Feb; 19(1 Pt 3):2113-4. PubMed ID: 3079073
[No Abstract] [Full Text] [Related]
7. [Use of delayed cyclosporin A in after administration of anti-lymphocyte serum in kidney transplantation].
Hourmant M; Soulillou JP
Biomed Pharmacother; 1987; 41(5):247-9. PubMed ID: 3311191
[TBL] [Abstract][Full Text] [Related]
8. Elective vs systematic corticosteroid withdrawal in renal transplant recipients receiving triple drug therapy.
Hiesse C; Rousseau P; Kriaa F; Larue JR; Charpentier B
Transplant Proc; 1995 Feb; 27(1):1066-7. PubMed ID: 7878807
[No Abstract] [Full Text] [Related]
9. Use of cyclosporine and Minnesota antilymphoblast globulin in the early postoperative treatment of primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Oh HK; Dienst S; Levin NW
Transplant Proc; 1987 Feb; 19(1 Pt 3):1882-5. PubMed ID: 3547893
[No Abstract] [Full Text] [Related]
10. Sequential conventional immunotherapy with maintenance cyclosporine following renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1986 Apr; 18(2 Suppl 1):69-75. PubMed ID: 3515698
[No Abstract] [Full Text] [Related]
11. Peri-operative antilymphoblast globulin (ALG) and delayed initiation of cyclosporine (CsA) diminishes the requirement for prolonged dialysis therapy after renal transplantation.
Nestor ZJ; Rocher LL; Merion RM; Swartz RD; Turcotte JG; Campbell DA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1556-7. PubMed ID: 2652505
[No Abstract] [Full Text] [Related]
12. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
Griñó JM; Bas J; Gonzalez C; Castelao AM; Seron D; Mestre M; Buendia E; Sabate R; Diaz C; Alsina J
Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
[No Abstract] [Full Text] [Related]
13. Low-dose cyclosporine, ALG, and steroids in first cadaveric renal transplants.
Griño JM; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andres E; Sabater R; Alsina J
Transplant Proc; 1987 Oct; 19(5):3674-6. PubMed ID: 3313887
[No Abstract] [Full Text] [Related]
14. Effect of initial versus delayed cyclosporine therapy in cadaveric renal transplant patients.
Lewis R; Hodge E; Novick A; Steinmuller D; Streem S; Cunningham R; Swift C; Goormastic M; Badhwar K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2088-92. PubMed ID: 3029914
[No Abstract] [Full Text] [Related]
15. Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone.
Hiesse C; Fries D; Charpentier B; Neyrat N; Rieu P; Cantarovich M; Lantz O; Bellamy J; Benoit G
Transplant Proc; 1987 Oct; 19(5):3670-1. PubMed ID: 3313885
[No Abstract] [Full Text] [Related]
16. [Prevention and treatment of graft rejection in kidney transplantation].
Callís L; Fortuny G; Lara E
An Esp Pediatr; 1989 Sep; 31 Suppl 39():44-6. PubMed ID: 2490327
[No Abstract] [Full Text] [Related]
17. Low-dose cyclosporine and antithymocyte globulin improve renal allograft survival in highly sensitized patients.
Palmer A; Bewick M; Welsh K; Snowden S; Parsons V; Taube D
Transplant Proc; 1988 Jun; 20(3 Suppl 3):198-200. PubMed ID: 3291241
[No Abstract] [Full Text] [Related]
18. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
[No Abstract] [Full Text] [Related]
19. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
Ono Y; Ohshima S; Fujita T; Kinukawa T; Matsuura O; Hirabayashi S; Takeuchi N
Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
[No Abstract] [Full Text] [Related]
20. Antilymphoblast globulin treatment of steroid-resistant rejection in cyclosporine-immunosuppressed renal transplant recipients.
Tellis VA; Matas AJ; Quinn TA; Glicklich D; Weiss RJ; Soberman RJ; Veith FJ
Transplant Proc; 1987 Feb; 19(1 Pt 3):1892. PubMed ID: 3274447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
